Naringin Alleviates Knee Osteoarthritis by Targeting TNF-α and PTGS2: An Integrated Network Pharmacology, Molecular Simulation, and Experimental Validation Study
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27041812 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Haidong Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China. Hauptthemen laut MEDLINE: Flavanones, Cyclooxygenase 2, Tumor Necrosis Factor-alpha, Osteoarthritis, Knee. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Jiangxi Provincial Key Research and Development Program, Jiangxi Provincial Key Research and Development Program.
Abstract (Originalsprache)
Knee osteoarthritis (KOA) is a chronic degenerative joint disorder driven largely by persistent inflammation and progressive cartilage damage. Naringin, a bioactive flavonoid abundant in citrus fruits, has shown potential anti-inflammatory effects; however, its molecular mechanisms in KOA remain unclear. In this study, an integrated approach combining network pharmacology, molecular docking, molecular dynamics (MD) simulations, and in vitro experiments was employed to investigate the anti-inflammatory effects of naringin in KOA. Network pharmacology analysis identified 59 potential KOA-related targets of naringin, among which TNF, PTGS2, TP53, CASP3, and PPARG were recognized as core targets. Functional enrichment indicated these targets were primarily associated with inflammation- and apoptosis-related pathways, especially the TNF and IL-17 signaling pathways. Molecular docking and MD simulations revealed strong binding affinity and stable interactions between naringin and the key inflammatory mediators TNF-α and PTGS2. In an IL-1β-stimulated C28/I2 human chondrocyte model, naringin dose-dependently improved cell viability and significantly suppressed TNF-α and PTGS2 expression at both mRNA and protein levels. These findings provide mechanistic evidence that naringin alleviates KOA-associated chondrocyte inflammation by modulating key inflammatory mediators, supporting its potential as an anti-inflammatory therapeutic candidate for KOA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
- School of Acupuncture and Tuina, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
ORCID-Profile: Yuwen Chen, Fengting Zhang
Förderung
- the Jiangxi Provincial Key Research and Development Program
- Jiangxi Provincial Key Research and Development Program
Zitieren
APA
Zhou, H., Zhou, J., Lu, Y., Luo, H., Hu, W., Xie, J., Wu, X., Li, B., Fan, S., Chen, Y., & Zhang, F. (2026). Naringin Alleviates Knee Osteoarthritis by Targeting TNF-α and PTGS2: An Integrated Network Pharmacology, Molecular Simulation, and Experimental Validation Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27041812
Vancouver
Zhou H, Zhou J, Lu Y, Luo H, Hu W, Xie J, et al. Naringin Alleviates Knee Osteoarthritis by Targeting TNF-α and PTGS2: An Integrated Network Pharmacology, Molecular Simulation, and Experimental Validation Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27041812
BibTeX
@article{Zhou2026,
author = {Zhou, Haidong and Zhou, Junjie and Lu, Yaohong and Luo, Hui and Hu, Wentao and Xie, Jiefei and Wu, Xinping and Li, Bo and Fan, Shaoyong and Chen, Yuwen and Zhang, Fengting},
title = {Naringin Alleviates Knee Osteoarthritis by Targeting TNF-α and PTGS2: An Integrated Network Pharmacology, Molecular Simulation, and Experimental Validation Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27041812}
}
EUVIMED